Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""T-cell"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 151959
Tytuł:
Copy Number Loss at Chromosome 14q11.2 Correlates With the Proportion of T Cells in Biopsies and Helps Identify T-Cell Neoplasms.
Autorzy:
Saglam A; From the Department of Pathology, Hacettepe University, Ankara, Turkey (Saglam).
Singh K; The Department of Pathology, University of California San Francisco, San Francisco (K Singh, Gollapudi, Mukherjee, A Singh, Butzmann, Rajkovic, Wen, Van Ziffle, Devine, Ohgami).
Kumar J; The Department of Pathology, Stanford University, Stanford, California (Kumar).
Gollapudi S; The Department of Pathology, University of California San Francisco, San Francisco (K Singh, Gollapudi, Mukherjee, A Singh, Butzmann, Rajkovic, Wen, Van Ziffle, Devine, Ohgami).
Mukherjee S; The Department of Pathology, University of California San Francisco, San Francisco (K Singh, Gollapudi, Mukherjee, A Singh, Butzmann, Rajkovic, Wen, Van Ziffle, Devine, Ohgami).
Singh A; The Department of Pathology, University of California San Francisco, San Francisco (K Singh, Gollapudi, Mukherjee, A Singh, Butzmann, Rajkovic, Wen, Van Ziffle, Devine, Ohgami).
Butzmann A; The Department of Pathology, University of California San Francisco, San Francisco (K Singh, Gollapudi, Mukherjee, A Singh, Butzmann, Rajkovic, Wen, Van Ziffle, Devine, Ohgami).
Kaplan L; Division of Hematology and Oncology, Department of Medicine & Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco (Kaplan, Andreadis, Ai, Fakhri).
Andreadis C; Division of Hematology and Oncology, Department of Medicine & Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco (Kaplan, Andreadis, Ai, Fakhri).
Ai WZ; Division of Hematology and Oncology, Department of Medicine & Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco (Kaplan, Andreadis, Ai, Fakhri).
Fakhri B; Division of Hematology and Oncology, Department of Medicine & Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco (Kaplan, Andreadis, Ai, Fakhri).
Rajkovic A; The Department of Pathology, University of California San Francisco, San Francisco (K Singh, Gollapudi, Mukherjee, A Singh, Butzmann, Rajkovic, Wen, Van Ziffle, Devine, Ohgami).
Wen KW; The Department of Pathology, University of California San Francisco, San Francisco (K Singh, Gollapudi, Mukherjee, A Singh, Butzmann, Rajkovic, Wen, Van Ziffle, Devine, Ohgami).
Onodera C; The Department of Genomics, Clinical Cancer Genomics Laboratory, University of California San Francisco, San Francisco (Onodera).
Van Ziffle J; The Department of Pathology, University of California San Francisco, San Francisco (K Singh, Gollapudi, Mukherjee, A Singh, Butzmann, Rajkovic, Wen, Van Ziffle, Devine, Ohgami).
Devine PW; The Department of Pathology, University of California San Francisco, San Francisco (K Singh, Gollapudi, Mukherjee, A Singh, Butzmann, Rajkovic, Wen, Van Ziffle, Devine, Ohgami).
Ohgami RS; The Department of Pathology, University of California San Francisco, San Francisco (K Singh, Gollapudi, Mukherjee, A Singh, Butzmann, Rajkovic, Wen, Van Ziffle, Devine, Ohgami).
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2023 Aug 01; Vol. 147 (8), pp. 940-948.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma, B-Cell*/genetics
Hodgkin Disease*/diagnosis
Hodgkin Disease*/genetics
Lymphoma, T-Cell*/diagnosis
Lymphoma, T-Cell*/genetics
Lymphoma, T-Cell, Peripheral*/genetics
Humans ; DNA Copy Number Variations ; Homozygote ; Retrospective Studies ; T-Lymphocytes ; Sequence Deletion ; Biopsy ; Chromosomes ; Receptors, Antigen, T-Cell/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Human thymic putative CD8αα precursors exhibit a biased TCR repertoire in single cell AIRR-seq.
Autorzy:
Heimli M; Department of Medical Genetics, University of Oslo and Oslo University Hospital, 0424, Oslo, Norway.
Tennebø Flåm S; Department of Medical Genetics, University of Oslo and Oslo University Hospital, 0424, Oslo, Norway.
Sagsveen Hjorthaug H; Department of Medical Genetics, University of Oslo and Oslo University Hospital, 0424, Oslo, Norway.
Bjørnstad PM; Department of Medical Genetics, University of Oslo and Oslo University Hospital, 0424, Oslo, Norway.
Chernigovskaya M; Department of Immunology, University of Oslo and Oslo University Hospital, 0372, Oslo, Norway.
Le QK; Department of Immunology, University of Oslo and Oslo University Hospital, 0372, Oslo, Norway.
Tekpli X; Department of Medical Genetics, University of Oslo and Oslo University Hospital, 0424, Oslo, Norway.
Greiff V; Department of Immunology, University of Oslo and Oslo University Hospital, 0372, Oslo, Norway.
Lie BA; Department of Medical Genetics, University of Oslo and Oslo University Hospital, 0424, Oslo, Norway. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Oct 18; Vol. 13 (1), pp. 17714. Date of Electronic Publication: 2023 Oct 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Receptors, Antigen, T-Cell*/metabolism
Thymocytes*/metabolism
Humans ; Child ; Thymus Gland/metabolism ; T-Lymphocytes, Regulatory ; Complementarity Determining Regions/genetics ; Complementarity Determining Regions/metabolism ; Cell Differentiation ; Receptors, Antigen, T-Cell, alpha-beta/genetics ; Receptors, Antigen, T-Cell, alpha-beta/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Isoforms of the TAL1 transcription factor have different roles in hematopoiesis and cell growth.
Autorzy:
Sharma A; Faculty of Medicine, Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Jerusalem, Israel.
Mistriel-Zerbib S; Faculty of Medicine, The Lautenberg Center for Immunology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Jerusalem, Israel.
Najar RA; Faculty of Medicine, Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Jerusalem, Israel.
Engal E; Faculty of Medicine, Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Jerusalem, Israel.
Bentata M; Faculty of Medicine, Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Jerusalem, Israel.
Taqatqa N; Faculty of Medicine, Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Jerusalem, Israel.
Dahan S; Faculty of Medicine, Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Jerusalem, Israel.
Cohen K; Faculty of Medicine, Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Jerusalem, Israel.
Jaffe-Herman S; Faculty of Medicine, Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Jerusalem, Israel.
Geminder O; Faculty of Medicine, Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Jerusalem, Israel.
Baker M; Faculty of Medicine, Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Jerusalem, Israel.
Nevo Y; Info-CORE, Bioinformatics Unit of the I-CORE Computation Center, The Hebrew University of Jerusalem, Jerusalem, Israel.
Plaschkes I; Info-CORE, Bioinformatics Unit of the I-CORE Computation Center, The Hebrew University of Jerusalem, Jerusalem, Israel.
Kay G; Faculty of Medicine, Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Jerusalem, Israel.
Drier Y; Faculty of Medicine, The Lautenberg Center for Immunology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Jerusalem, Israel.
Berger M; Faculty of Medicine, The Lautenberg Center for Immunology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Jerusalem, Israel.
Salton M; Faculty of Medicine, Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Jerusalem, Israel.
Pokaż więcej
Źródło:
PLoS biology [PLoS Biol] 2023 Jun 28; Vol. 21 (6), pp. e3002175. Date of Electronic Publication: 2023 Jun 28 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Basic Helix-Loop-Helix Transcription Factors*/genetics
Basic Helix-Loop-Helix Transcription Factors*/metabolism
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/metabolism
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Animals ; Mice ; Chromatin ; Hematopoiesis/genetics ; Protein Isoforms/genetics ; Proto-Oncogene Proteins/genetics ; Proto-Oncogene Proteins/metabolism ; T-Cell Acute Lymphocytic Leukemia Protein 1/genetics ; Transcription Factors/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cell activation-based screening of natively paired human T cell receptor repertoires.
Autorzy:
Fahad AS; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS, 66044, USA.
Chung CY; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS, 66044, USA.
López Acevedo SN; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS, 66044, USA.
Boyle N; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS, 66044, USA.
Madan B; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS, 66044, USA.
Gutiérrez-González MF; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS, 66044, USA.
Matus-Nicodemos R; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Laflin AD; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS, 66044, USA.
Ladi RR; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS, 66044, USA.
Zhou J; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS, 66044, USA.
Wolfe J; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS, 66044, USA.
Llewellyn-Lacey S; Division of Infection and Immunity, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, CF14 4XN, UK.
Koup RA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Douek DC; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Balfour HH Jr; Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN, 55455, USA.; Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN, 55455, USA.
Price DA; Division of Infection and Immunity, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, CF14 4XN, UK.; Systems Immunity Research Institute, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, CF14 4XN, UK.
DeKosky BJ; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS, 66044, USA. .; Department of Chemical Engineering, The University of Kansas, Lawrence, KS, 66044, USA. .; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA. .; The Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02139, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 May 17; Vol. 13 (1), pp. 8011. Date of Electronic Publication: 2023 May 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
MeSH Terms:
T-Lymphocytes*
Receptors, Antigen, T-Cell*
Humans ; Receptors, Antigen, T-Cell, alpha-beta/genetics ; Cloning, Molecular ; Antigens ; Peptides/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Single cell profiling of γδ hepatosplenic T-cell lymphoma unravels tumor cell heterogeneity associated with disease progression.
Autorzy:
Song W; Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, 650500, Yunnan, People's Republic of China.; School of Medicine, Kunming University of Science and Technology, Kunming, 650500, Yunnan, People's Republic of China.; Department of Radiology, The First People's Hospital of Yunnan Province, Kunming, 650032, Yunnan, People's Republic of China.
Zhang H; Department of Hematology, The First People's Hospital of Yunnan Province, Kunming, 650032, Yunnan, People's Republic of China.; Yunnan Province Clinical Center for Hematologic Disease, Kunming, 650032, Yunnan, People's Republic of China.; Yunnan Province Clinical Research Center for Hematologic Disease, Kunming, 650032, Yunnan, People's Republic of China.
Yang F; School of Medicine, Kunming University of Science and Technology, Kunming, 650500, Yunnan, People's Republic of China.
Nakahira K; Department of Pharmacology, Nara Medical University, Kashihara, Nara, 634-8521, Japan.; Division of Pulmonary and Critical Care Medicine, Weill Department of Medicine, Joan and Sanford I, Weill Cornell Medicine, New York, NY, 10065, USA.
Wang C; Innovec Biotherapeutics, Inc., Beijing, 100193, People's Republic of China.
Shi K; Department of Hematology, The First People's Hospital of Yunnan Province, Kunming, 650032, Yunnan, People's Republic of China. .; Yunnan Province Clinical Center for Hematologic Disease, Kunming, 650032, Yunnan, People's Republic of China. .; Yunnan Province Clinical Research Center for Hematologic Disease, Kunming, 650032, Yunnan, People's Republic of China. .
Zhang R; Innovec Biotherapeutics, Inc., Beijing, 100193, People's Republic of China. .
Pokaż więcej
Źródło:
Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2023 Feb; Vol. 46 (1), pp. 211-226. Date of Electronic Publication: 2022 Nov 22.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma, T-Cell*/diagnosis
Lymphoma, T-Cell*/genetics
Lymphoma, T-Cell*/pathology
Liver Neoplasms*/metabolism
Splenic Neoplasms*/diagnosis
Splenic Neoplasms*/genetics
Splenic Neoplasms*/pathology
Humans ; Receptors, Antigen, T-Cell, gamma-delta/analysis ; Receptors, Antigen, T-Cell, gamma-delta/genetics ; Receptors, Antigen, T-Cell, gamma-delta/metabolism ; Disease Progression ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical and Real-World Effectiveness of Mogamulizumab: A Narrative Review.
Autorzy:
Fernández-Guarino M; Dermatology Department, Hospital Universitario Ramón y Cajal, Instituto de Investigación Sanitaria Ramón y Cajal (Irycis), 28034 Madrid, Spain.
Ortiz P; Dermatology Department, Hospital 12 de Octubre, 28041 Madrid, Spain.
Gallardo F; Dermatology Department, Hospital del Mar, 08003 Barcelona, Spain.
Llamas-Velasco M; Dermatology Department, Hospital Universitario de la Princesa, Fundación de Investigación Biomédica de la Princesa, 28006 Madrid, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 12; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Lymphoma, T-Cell, Cutaneous*/drug therapy
Mycosis Fungoides*/pathology
Sezary Syndrome*/pathology
Leukemia-Lymphoma, Adult T-Cell*/drug therapy
Leukemia-Lymphoma, Adult T-Cell*/pathology
Skin Neoplasms*/pathology
Antibodies, Monoclonal, Humanized*
Adult ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Physiological and Functional Effects of Dominant Active TCRα Expression in Transgenic Mice.
Autorzy:
Kalinina AA; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Kashirskoe sh., 24, 115478 Moscow, Russia.
Ziganshin RK; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya st. 16/10, 117997 Moscow, Russia.
Silaeva YY; Institute of Gene Biology, Russian Academy of Sciences, Vavilova st. 34/5, 119334 Moscow, Russia.
Sharova NI; National Research Center, Institute of Immunology Federal Medical-Biological Agency of Russia, Kashirskoe sh., 24, 115522 Moscow, Russia.
Nikonova MF; National Research Center, Institute of Immunology Federal Medical-Biological Agency of Russia, Kashirskoe sh., 24, 115522 Moscow, Russia.
Persiyantseva NA; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Kashirskoe sh., 24, 115478 Moscow, Russia.
Gorkova TG; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Kashirskoe sh., 24, 115478 Moscow, Russia.
Antoshina EE; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Kashirskoe sh., 24, 115478 Moscow, Russia.
Trukhanova LS; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Kashirskoe sh., 24, 115478 Moscow, Russia.
Donetskova AD; National Research Center, Institute of Immunology Federal Medical-Biological Agency of Russia, Kashirskoe sh., 24, 115522 Moscow, Russia.
Komogorova VV; National Research Center, Institute of Immunology Federal Medical-Biological Agency of Russia, Kashirskoe sh., 24, 115522 Moscow, Russia.
Litvina MM; National Research Center, Institute of Immunology Federal Medical-Biological Agency of Russia, Kashirskoe sh., 24, 115522 Moscow, Russia.
Mitin AN; National Research Center, Institute of Immunology Federal Medical-Biological Agency of Russia, Kashirskoe sh., 24, 115522 Moscow, Russia.
Zamkova MA; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Kashirskoe sh., 24, 115478 Moscow, Russia.; Institute of Gene Biology, Russian Academy of Sciences, Vavilova st. 34/5, 119334 Moscow, Russia.
Bruter AV; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Kashirskoe sh., 24, 115478 Moscow, Russia.; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology, Russian Academy of Sciences, 34/5 Vavilov St., 119334 Moscow, Russia.
Khromykh LM; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Kashirskoe sh., 24, 115478 Moscow, Russia.
Kazansky DB; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Kashirskoe sh., 24, 115478 Moscow, Russia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Mar 30; Vol. 24 (7). Date of Electronic Publication: 2023 Mar 30.
Typ publikacji:
Journal Article
MeSH Terms:
T-Lymphocytes*
Receptors, Antigen, T-Cell, alpha-beta*
Mice ; Animals ; Mice, Transgenic ; Receptors, Antigen, T-Cell/genetics ; Receptors, Antigen, T-Cell/metabolism ; Lymphocytes/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinicopathological features of adult T-cell leukemia/lymphoma with T-follicular helper phenotype.
Autorzy:
Muto R; Department of Pathology, National Hospital Organization (NHO), Kumamoto Medical Center, Kumamoto, Japan.; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.; Department of Pathology, Fukuoka University School of Medicine, Fukuoka, Japan.
Miyoshi H; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
Nakashima K; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
Takeuchi M; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
Hamasaki M; Department of Pathology, Fukuoka University School of Medicine, Fukuoka, Japan.
Ohshima K; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (6), pp. e7050.
Typ publikacji:
Journal Article
MeSH Terms:
Leukemia-Lymphoma, Adult T-Cell*/diagnosis
Leukemia-Lymphoma, Adult T-Cell*/genetics
Lymphoma*/pathology
Adult ; Humans ; Prognosis ; Phenotype ; T-Lymphocytes, Helper-Inducer/metabolism ; T-Lymphocytes, Helper-Inducer/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Advanced Cutaneous Peripheral T-cell Lymphoma-Not Otherwise Specified with Extensive Ulceronecrotic Dyschromic Plaques and Poor Outcome
Autorzy:
Sharma V; Medicine Department at SMS Medical College, Jaipur, India
Bagrodia V; SMS Medical College, Jaipur, India
Pokaż więcej
Źródło:
Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2024 Mar 01; Vol. 41 (1), pp. 43-44. Date of Electronic Publication: 2023 Jul 10.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma, T-Cell, Peripheral*/complications
Lymphoma, T-Cell, Peripheral*/diagnosis
Lymphoma, T-Cell, Cutaneous*/complications
Lymphoma, T-Cell, Cutaneous*/diagnosis
Skin Neoplasms*/complications
Skin Neoplasms*/diagnosis
Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Full-spectral genome analysis of natural killer/T cell lymphoma highlights impacts of genome instability in driving its progression.
Autorzy:
Chen Z; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Huang H; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Hong H; Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, China.
Huang H; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Weng H; Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, China.
Yu L; Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, China.
Xiao J; Department of Medical Oncology, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510655, China.
Wang Z; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Fang X; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Yao Y; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Yue JX; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China. .
Lin T; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China. .; Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, China. .
Pokaż więcej
Źródło:
Genome medicine [Genome Med] 2024 Apr 02; Vol. 16 (1), pp. 48. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma, Extranodal NK-T-Cell*/genetics
Lymphoma, Extranodal NK-T-Cell*/pathology
Humans ; Mutation ; Genomic Instability ; Nucleotides ; Killer Cells, Natural ; Histone-Lysine N-Methyltransferase/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The RNA sequencing results revealed the expression of different genes and signaling pathways during chemotherapy resistance in peripheral T-cell lymphoma.
Autorzy:
Lan Y; Molecular Diagnostic Center, The Third Affiliated Hospital of Kunming Medical University, Kunming, China. .; International Joint Laboratory On High Altitude Regional Cancer, Kunming, China. .; Yunnan Key Laboratory of Lung Cancer Research, Kunming, China. .
Tao W; Department of Hematology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Ma L; Molecular Diagnostic Center, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.; International Joint Laboratory On High Altitude Regional Cancer, Kunming, China.; Yunnan Key Laboratory of Lung Cancer Research, Kunming, China.
Wang X; Molecular Diagnostic Center, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.; International Joint Laboratory On High Altitude Regional Cancer, Kunming, China.; Yunnan Key Laboratory of Lung Cancer Research, Kunming, China.
Li H; Molecular Diagnostic Center, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.; International Joint Laboratory On High Altitude Regional Cancer, Kunming, China.; Yunnan Key Laboratory of Lung Cancer Research, Kunming, China.
Du Y; Molecular Diagnostic Center, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.; International Joint Laboratory On High Altitude Regional Cancer, Kunming, China.; Yunnan Key Laboratory of Lung Cancer Research, Kunming, China.
Yang R; Molecular Diagnostic Center, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.; International Joint Laboratory On High Altitude Regional Cancer, Kunming, China.; Yunnan Key Laboratory of Lung Cancer Research, Kunming, China.
Wu S; Molecular Diagnostic Center, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.; International Joint Laboratory On High Altitude Regional Cancer, Kunming, China.; Yunnan Key Laboratory of Lung Cancer Research, Kunming, China.
Ou Y; Molecular Diagnostic Center, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.; International Joint Laboratory On High Altitude Regional Cancer, Kunming, China.; Yunnan Key Laboratory of Lung Cancer Research, Kunming, China.
Liu X; Molecular Diagnostic Center, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.; International Joint Laboratory On High Altitude Regional Cancer, Kunming, China.; Yunnan Key Laboratory of Lung Cancer Research, Kunming, China.
Huang Y; International Joint Laboratory On High Altitude Regional Cancer, Kunming, China.; Yunnan Key Laboratory of Lung Cancer Research, Kunming, China.
Zhou Y; Molecular Diagnostic Center, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.; International Joint Laboratory On High Altitude Regional Cancer, Kunming, China.; Yunnan Key Laboratory of Lung Cancer Research, Kunming, China.
Pokaż więcej
Źródło:
BMC medical genomics [BMC Med Genomics] 2024 Mar 11; Vol. 17 (1), pp. 74. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma, T-Cell, Peripheral*/drug therapy
Lymphoma, T-Cell, Peripheral*/genetics
Humans ; Neoplasm Recurrence, Local ; Gene Expression Profiling/methods ; Signal Transduction/genetics ; Sequence Analysis, RNA
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Investigation of occupational risk factors for the development of non-Hodgkin's lymphoma in adults: A hospital-based case-control study.
Autorzy:
Sarpa M; Coordination of Prevention and Surveillance, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.; Environmental Mutagenesis Laboratory, Federal University of Rio de Janeiro State (UNIRIO), Rio de Janeiro, Brazil.
da Costa VÍDB; Coordination of Prevention and Surveillance, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
Ferreira SN; Coordination of Prevention and Surveillance, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.; Environmental Mutagenesis Laboratory, Federal University of Rio de Janeiro State (UNIRIO), Rio de Janeiro, Brazil.
de Almeida CÁ; Coordination of Prevention and Surveillance, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.; Environmental Mutagenesis Laboratory, Federal University of Rio de Janeiro State (UNIRIO), Rio de Janeiro, Brazil.
de Oliveira PGS; Coordination of Prevention and Surveillance, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.; Environmental Mutagenesis Laboratory, Federal University of Rio de Janeiro State (UNIRIO), Rio de Janeiro, Brazil.
de Mesquita LV; Coordination of Prevention and Surveillance, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.; Environmental Mutagenesis Laboratory, Federal University of Rio de Janeiro State (UNIRIO), Rio de Janeiro, Brazil.
Schilithz AOC; Coordination of Prevention and Surveillance, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
Stefanoff CG; Coordination of Clinical Research and Technological Incorporation, Brazilian National Cancer Institute, Rio de Janeiro, RJ, Brazil.
Hassan R; Oncovirology Laboratory, Bone Marrow Transplantation Center, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.
Otero UB; Coordination of Prevention and Surveillance, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 26; Vol. 19 (2), pp. e0297140. Date of Electronic Publication: 2024 Feb 26 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Occupational Exposure*/adverse effects
Lymphoma, T-Cell*
Lymphoma, T-Cell, Peripheral*
Lymphoma, B-Cell*
Pesticides*
Adult ; Humans ; Case-Control Studies ; Risk Factors ; Solvents/adverse effects ; Hydrocarbons
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Liquid biopsy in T-cell lymphoma: biomarker detection techniques and clinical application.
Autorzy:
Huang Z; Department of Pathology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Fu Y; Department of Pathology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Yang H; Department of Pathology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Zhou Y; Department of Pathology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Shi M; Department of Pathology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Li Q; Genecast Biotechnology Co., Ltd, Wuxi, 214104, China.
Liu W; Department of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Liang J; Nanjing Geneseeq Technology Inc., Nanjing, 210032, Jiangsu, China.
Zhu L; Nanjing Geneseeq Technology Inc., Nanjing, 210032, Jiangsu, China.
Qin S; Department of Pathology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China. .
Hong H; Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China. .
Liu Y; Department of Pathology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2024 Feb 17; Vol. 23 (1), pp. 36. Date of Electronic Publication: 2024 Feb 17.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Epstein-Barr Virus Infections*
Lymphoma, T-Cell*/diagnosis
Lymphoma, T-Cell*/genetics
Humans ; Reproducibility of Results ; Biomarkers, Tumor/genetics ; Herpesvirus 4, Human ; Liquid Biopsy/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinicopathological comparison between PTCL-TBX21 and PTCL-GATA3 in Japanese patients.
Autorzy:
Shimasaki Y; Department of Pathology, School of Medicine, Kurume University, Kurume, Japan.; Department of Hematology, Shimane University Hospital, Izumo, Japan.
Miyoshi H; Department of Pathology, School of Medicine, Kurume University, Kurume, Japan.
Kawamoto K; Department of Pathology, School of Medicine, Kurume University, Kurume, Japan.; Department of Hematology, Endocrinology, and Metabolism, Faculty of Medicine, Niigata University, Niigata, Japan.
Yoshida N; Department of Pathology, School of Medicine, Kurume University, Kurume, Japan.; Department of Clinical Studies, Radiation Effects Research Foundation, Hiroshima, Japan.
Mishina T; Department of Pathology, School of Medicine, Kurume University, Kurume, Japan.; Department of Hematology, Chiba University Hospital, Chiba, Japan.
Nakashima K; Department of Pathology, School of Medicine, Kurume University, Kurume, Japan.
Imamoto T; Department of Pathology, School of Medicine, Kurume University, Kurume, Japan.; Department of Surgical Pathology, Hokkaido University Hospital, Sapporo, Japan.
Sugio T; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yanagida E; Department of Pathology, School of Medicine, Kurume University, Kurume, Japan.
Kato T; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Yamada K; Department of Pathology, School of Medicine, Kurume University, Kurume, Japan.
Takeuchi M; Department of Pathology, School of Medicine, Kurume University, Kurume, Japan.
Suzuki T; Department of Hematology, Endocrinology, and Metabolism, Faculty of Medicine, Niigata University, Niigata, Japan.
Moritsubo M; Department of Pathology, School of Medicine, Kurume University, Kurume, Japan.
Furuta T; Department of Pathology, School of Medicine, Kurume University, Kurume, Japan.
Imaizumi Y; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Takizawa J; Department of Hematology, Endocrinology, and Metabolism, Faculty of Medicine, Niigata University, Niigata, Japan.
Kato K; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Suzumiya J; Department of Hematology, Kohga Hospital, Yaizu, Japan.
Suzuki R; Department of Hematology, Shimane University Hospital, Izumo, Japan.
Ohshima K; Department of Pathology, School of Medicine, Kurume University, Kurume, Japan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e6793. Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:
Journal Article
MeSH Terms:
Algorithms*
Lymphoma, T-Cell, Peripheral*/drug therapy
Lymphoma, T-Cell, Peripheral*/genetics
Humans ; Japan ; Gene Expression Profiling ; Immune Checkpoint Inhibitors ; GATA3 Transcription Factor/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALL.
Autorzy:
Smith C; Université de Paris Cité, Institut Necker Enfants-Malades INEM, Institut National de La Santé Et de La Recherche Médicale (Inserm), U1151, Paris, France.; Laboratory of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades 75743, Paris, France.
Touzart A; Université de Paris Cité, Institut Necker Enfants-Malades INEM, Institut National de La Santé Et de La Recherche Médicale (Inserm), U1151, Paris, France.; Laboratory of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades 75743, Paris, France.
Simonin M; Université de Paris Cité, Institut Necker Enfants-Malades INEM, Institut National de La Santé Et de La Recherche Médicale (Inserm), U1151, Paris, France.; Laboratory of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades 75743, Paris, France.
Tran-Quang C; Institut Curie, Orsay, France.; CNRS UMR3348, Institut Curie, Orsay, France.; INSERM U1278, Centre Universitaire, Orsay, France.; PSL Research University, Paris, France.; University Paris-Saclay, 91400, Orsay, France.
Hypolite G; Université de Paris Cité, Institut Necker Enfants-Malades INEM, Institut National de La Santé Et de La Recherche Médicale (Inserm), U1151, Paris, France.; Laboratory of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades 75743, Paris, France.
Latiri M; Université de Paris Cité, Institut Necker Enfants-Malades INEM, Institut National de La Santé Et de La Recherche Médicale (Inserm), U1151, Paris, France.; Laboratory of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades 75743, Paris, France.
Andrieu GP; Université de Paris Cité, Institut Necker Enfants-Malades INEM, Institut National de La Santé Et de La Recherche Médicale (Inserm), U1151, Paris, France.; Laboratory of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades 75743, Paris, France.
Balducci E; Université de Paris Cité, Institut Necker Enfants-Malades INEM, Institut National de La Santé Et de La Recherche Médicale (Inserm), U1151, Paris, France.; Laboratory of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades 75743, Paris, France.
Dourthe MÉ; Université de Paris Cité, Institut Necker Enfants-Malades INEM, Institut National de La Santé Et de La Recherche Médicale (Inserm), U1151, Paris, France.; Laboratory of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades 75743, Paris, France.; Department of Pediatric Hematology and Immunology, Assistance Publique-Hôpitaux de Paris (AP-HP), Robert Debré Hospital, Université de Paris Cité, Paris, France.
Goyal A; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Huguet F; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Laboratoire d'Hématologie, Toulouse, France.
Petit A; Service d'Hématologie Et d'Oncologie Pédiatrique, AP-HP, Hôpital Armand Trousseau, Sorbonne Université, Paris, France.
Ifrah N; UFR Santé, Université Angers, PRES LUNAM, Centre Hospitalier-Universitaire (CHU) d'Angers, Service Des Maladies du Sang Et INSERM U892, 49933, Angers, France.
Baruchel A; Department of Pediatric Hematology and Immunology, Assistance Publique-Hôpitaux de Paris (AP-HP), Robert Debré Hospital, Université de Paris Cité, Paris, France.
Dombret H; Université de Paris Cité, Institut Universitaire d'Hématologie, EA-3518, Assistance Publique-Hôpitaux de Paris, University Hospital Saint-Louis, Paris, France.
Macintyre E; Université de Paris Cité, Institut Necker Enfants-Malades INEM, Institut National de La Santé Et de La Recherche Médicale (Inserm), U1151, Paris, France.; Laboratory of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades 75743, Paris, France.
Plass C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; German Cancer Research Consortium (DKTK), 69120, Heidelberg, Germany.
Ghysdael J; Institut Curie, Orsay, France.; CNRS UMR3348, Institut Curie, Orsay, France.; INSERM U1278, Centre Universitaire, Orsay, France.; PSL Research University, Paris, France.; University Paris-Saclay, 91400, Orsay, France.
Boissel N; Université de Paris Cité, Institut Universitaire d'Hématologie, EA-3518, Assistance Publique-Hôpitaux de Paris, University Hospital Saint-Louis, Paris, France.
Asnafi V; Université de Paris Cité, Institut Necker Enfants-Malades INEM, Institut National de La Santé Et de La Recherche Médicale (Inserm), U1151, Paris, France. .; Laboratory of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades 75743, Paris, France. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2023 Jan 18; Vol. 22 (1), pp. 12. Date of Electronic Publication: 2023 Jan 18.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/metabolism
Humans ; Proto-Oncogene Proteins/genetics ; Proto-Oncogene Proteins/metabolism ; T-Cell Acute Lymphocytic Leukemia Protein 1/genetics ; Basic Helix-Loop-Helix Transcription Factors/genetics ; Mebendazole
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of Novel Targets, Including CC-Chemokine Receptor 4, in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Mayo Clinic Clinical and Pathologic Study.
Autorzy:
Khurana S; From the Division of Hematology/Oncology, University of Arizona Cancer Center, Tucson (Khurana).
Heckman MG; the Departments of Biomedical Statistics and Informatics (Heckman, Cochuyt) and Laboratory Medicine and Pathology (Jiang), and the Division of Hematology and Medical Oncology (Foran), Mayo Clinic Florida, Jacksonville.
Craig FE; the Divisions of Hematopathology (Craig) and Hematology and Medical Oncology (Sproat), Mayo Clinic Arizona, Phoenix.
Cochuyt JJ; the Departments of Biomedical Statistics and Informatics (Heckman, Cochuyt) and Laboratory Medicine and Pathology (Jiang), and the Division of Hematology and Medical Oncology (Foran), Mayo Clinic Florida, Jacksonville.
Greipp P; the Divisions of Laboratory Genetics (Greipp) and Hematology (Litzow), Mayo Clinic, Rochester, Minnesota.
Rahman ZA; the Division of Hematology and Medical Oncology, Sanford Roger Maris Cancer Center, Fargo, North Dakota (Rahman).
Sproat LZ; the Divisions of Hematopathology (Craig) and Hematology and Medical Oncology (Sproat), Mayo Clinic Arizona, Phoenix.
Litzow M; the Divisions of Laboratory Genetics (Greipp) and Hematology (Litzow), Mayo Clinic, Rochester, Minnesota.
Foran JM; the Departments of Biomedical Statistics and Informatics (Heckman, Cochuyt) and Laboratory Medicine and Pathology (Jiang), and the Division of Hematology and Medical Oncology (Foran), Mayo Clinic Florida, Jacksonville.
Jiang LJ; the Departments of Biomedical Statistics and Informatics (Heckman, Cochuyt) and Laboratory Medicine and Pathology (Jiang), and the Division of Hematology and Medical Oncology (Foran), Mayo Clinic Florida, Jacksonville.
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 Apr 01; Vol. 148 (4), pp. 471-475.
Typ publikacji:
Journal Article
MeSH Terms:
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Lymphoma*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Lymphoma, B-Cell*
Adult ; Humans ; CD47 Antigen ; Receptors, CCR4 ; Interleukin-3 Receptor alpha Subunit ; T-Lymphocytes/pathology ; Proto-Oncogene Proteins c-bcl-2
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets.
Autorzy:
Guglielmo A; Institute of Dermatology, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), 33100 Udine, Italy.; Dipartimento di Scienze Mediche e Chirurgiche, University of Bologna, 40138 Bologna, Italy.
Zengarini C; Dipartimento di Scienze Mediche e Chirurgiche, University of Bologna, 40138 Bologna, Italy.; Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Agostinelli C; Dipartimento di Scienze Mediche e Chirurgiche, University of Bologna, 40138 Bologna, Italy.; Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Motta G; Dipartimento di Scienze Mediche e Chirurgiche, University of Bologna, 40138 Bologna, Italy.; Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Sabattini E; Dipartimento di Scienze Mediche e Chirurgiche, University of Bologna, 40138 Bologna, Italy.; Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Pileri A; Dipartimento di Scienze Mediche e Chirurgiche, University of Bologna, 40138 Bologna, Italy.; Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Mar 28; Vol. 13 (7). Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Skin Neoplasms*/drug therapy
Skin Neoplasms*/etiology
Lymphoma, T-Cell, Cutaneous*/drug therapy
Lymphoma, T-Cell, Cutaneous*/pathology
Mycosis Fungoides*/pathology
Sezary Syndrome*/therapy
Sezary Syndrome*/genetics
Humans ; Cytokines/genetics ; Interferon-gamma ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association of TRAIL receptor with phosphatase SHP-1 enables repressing T cell receptor signaling and T cell activation through inactivating Lck.
Autorzy:
Chyuan IT; School of Medicine, National Tsing Hua University, Hsinchu, 30013, Taiwan.; Department of Medical Research, Cathay General Hospital, Taipei, 10630, Taiwan.; Department of Internal Medicine, Cathay General Hospital, Taipei, 10630, Taiwan.
Liao HJ; Department of Medical Research, Far Eastern Memorial Hospital, New Taipei City, Taipei, 22000, Taiwan.; Institute of Biopharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, 112304, Taiwan.
Tan TH; Immunology Research Center, National Health Research Institutes, Zhunan, 35053, Taiwan.; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, 77030, USA.
Chuang HC; Immunology Research Center, National Health Research Institutes, Zhunan, 35053, Taiwan.
Chu YC; Department of Medical Research, Cathay General Hospital, Taipei, 10630, Taiwan.
Pan MH; Department of Medical Research, Cathay General Hospital, Taipei, 10630, Taiwan.
Wu CS; Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taipei, 22000, Taiwan.
Chu CL; Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, 10051, Taiwan.
Sheu BC; Department of Obstetrics and Gynecology, College of Medicine, National Taiwan University Hospital, National Taiwan University, Taipei, 10002, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, 10051, Taiwan.
Hsu PN; Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, 10051, Taiwan. .; Department of Internal Medicine and Graduate Institute of Immunology, College of Medicine, National Taiwan University, 1 Jen-Ai Rd., Sec. 1, Taipei, 10051, Taiwan. .; Department of Internal Medicine, National Taiwan University Hospital, Taipei, 10002, Taiwan. .
Pokaż więcej
Źródło:
Journal of biomedical science [J Biomed Sci] 2024 Mar 27; Vol. 31 (1), pp. 33. Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:
Journal Article
MeSH Terms:
Receptors, TNF-Related Apoptosis-Inducing Ligand*/metabolism
Receptors, Antigen, T-Cell*/metabolism
Humans ; Jurkat Cells ; Protein Tyrosine Phosphatase, Non-Receptor Type 6/metabolism ; Signal Transduction ; Protein Tyrosine Phosphatases/genetics ; Protein Tyrosine Phosphatases/metabolism ; Phosphorylation ; Lymphocyte Activation ; Tyrosine/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center.
Autorzy:
Singh M; Haematology-Oncology Unit, Department of Paediatrics, Postgraduate Institute of Medical Education and Research, Sector -12, 160012, Chandigarh, India. .
Sharma P; Haematology-Oncology Unit, Department of Paediatrics, Postgraduate Institute of Medical Education and Research, Sector -12, 160012, Chandigarh, India.
Bhatia P; Haematology-Oncology Unit, Department of Paediatrics, Postgraduate Institute of Medical Education and Research, Sector -12, 160012, Chandigarh, India.
Trehan A; Haematology-Oncology Unit, Department of Paediatrics, Postgraduate Institute of Medical Education and Research, Sector -12, 160012, Chandigarh, India.
Thakur R; Haematology-Oncology Unit, Department of Paediatrics, Postgraduate Institute of Medical Education and Research, Sector -12, 160012, Chandigarh, India.
Sreedharanunni S; Department of Haematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 08; Vol. 24 (1), pp. 325. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Child ; Humans ; Child, Preschool ; Transcriptome ; Tertiary Care Centers ; Transcription Factors/genetics ; Mutation ; T-Lymphocytes ; Prognosis ; Formins/genetics ; Histone Deacetylases ; Repressor Proteins/genetics ; Receptors, Lysophosphatidic Acid/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Circulating Monocytes Phagocytosing Lymphocytes in the Small-Cell Variant of T-Cell Prolymphocytic Leukemia
Autorzy:
Zhang S; The District People’s Hospital of Zhangqiu, Department of Emergency, Jinan, China
Ma M; The District People’s Hospital of Zhangqiu, Department of Emergency, Jinan, China
Liu Y; The District People’s Hospital of Zhangqiu, Department of Emergency, Jinan, China
Bu Y; The District People’s Hospital of Zhangqiu, Department of Emergency, Jinan, China
Zhang Z; The District People’s Hospital of Zhangqiu, Department of Emergency, Jinan, China
Zhang Y; The District People’s Hospital of Zhangqiu, Department of Clinical Laboratory, Jinan, China
Pokaż więcej
Źródło:
Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2024 Mar 01; Vol. 41 (1), pp. 53-54. Date of Electronic Publication: 2023 Dec 28.
Typ publikacji:
Journal Article
MeSH Terms:
Leukemia, Prolymphocytic, T-Cell*/diagnosis
Humans ; Monocytes ; Lymphocytes ; Immunophenotyping
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 151959

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies